Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Gains from Investment Securities (2017 - 2026)

Summit Therapeutics filings provide 9 years of Gains from Investment Securities readings, the most recent being $1.0 million for Q1 2026.

  • Quarterly Gains from Investment Securities fell 27.7% to $1.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Mar 2026, up 106.2% year-over-year, with the annual reading at $17.1 million for FY2025, 304.55% up from the prior year.
  • Gains from Investment Securities hit $1.0 million in Q1 2026 for Summit Therapeutics, down from $16.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $16.2 million in Q4 2025 and bottomed at -$2.9 million in Q3 2025.
  • Average Gains from Investment Securities over 5 years is $2.7 million, with a median of $1.8 million recorded in 2025.
  • The largest annual shift saw Gains from Investment Securities crashed 317.87% in 2022 before it skyrocketed 158.01% in 2025.
  • Summit Therapeutics' Gains from Investment Securities stood at -$2.8 million in 2022, then skyrocketed by 254.03% to $4.2 million in 2023, then surged by 56.94% to $6.7 million in 2024, then skyrocketed by 143.79% to $16.2 million in 2025, then crashed by 93.68% to $1.0 million in 2026.
  • Per Business Quant, the three most recent readings for SMMT's Gains from Investment Securities are $1.0 million (Q1 2026), $16.2 million (Q4 2025), and -$2.9 million (Q3 2025).